PRKAB1 and Insulin resistance: AMPK functions as a central regulator of energy utilization and its dysfunction is associated with the onset of obesity, disruptions in glucose homeostasis, and the development of insulin resistance in insulin-sensitive tissues such as liver and skeletal muscle [24,25].